Antiangiogenic therapy in breast cancer.

about

Antiangiogenic therapy in breast cancer.

Item

http://www.wikidata.org/entity/Q47111400

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Antiangiogenic therapy in breast cancer.

@en

Antiangiogenic therapy in breast cancer.

@nl

type

Item

label

Antiangiogenic therapy in breast cancer.

@en

Antiangiogenic therapy in breast cancer.

@nl

prefLabel

Antiangiogenic therapy in breast cancer.

@en

Antiangiogenic therapy in breast cancer.

@nl

P1476

Antiangiogenic therapy in breast cancer.

@en

P2093

Richard Greil

http://www.w3.org/2001/XMLSchema#string

Simon Peter Gampenrieder

http://www.w3.org/2001/XMLSchema#string

Theresa Westphal

http://www.w3.org/2001/XMLSchema#string

P2860

Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis

Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer

First-line bevacizumab in combination with chemotherapy for HER2-negative metastatic breast cancer: pooled and subgroup analyses of data from 2447 patients.

Phase III study of bevacizumab plus docetaxel compared with placebo plus docetaxel for the first-line treatment of human epidermal growth factor receptor 2-negative metastatic breast cancer.

VEGF as a mediator of tumor-associated immunodeficiency.

Immune consequences of decreasing tumor vasculature with antiangiogenic tyrosine kinase inhibitors in combination with therapeutic vaccines.

Bevacizumab plus ipilimumab in patients with metastatic melanoma.

Microvessel density as a prognostic factor in women with breast cancer: a systematic review of the literature and meta-analysis.

Randomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer.

Influence of the American ODAC statement on Austrian bevacizumab prescribing practice for metastatic breast cancer.

P2888

s12254-017-0362-0

P304

194-201

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1007/S12254-017-0362-0

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29250196

http://www.w3.org/2001/XMLSchema#string

P932

5725520

http://www.w3.org/2001/XMLSchema#string